A Case Series of Patients with COVID-19 Infection Admitted to a Secondary Care Center in Turkey

Case Series, COVID-19, Turkey


Introduction: COVID-19 is a zoonotic viral infection that first emerged in Wuhan, China, the source of which is thought to be a seafood market, and then spread rapidly from China to the world. Objective: The aim of this observational study was to analyze cases with COVID-19 admitted to a single secondary care center in Turkey. Methods: This is a descriptive study performed during the period from March 22 to 30, 2020, in Kars Harakani State Hospital, Kars, Turkey. We evaluated all patients with reverse transcription polymerase chain reaction (RT-PCR) to confirm COVID-19. Demographic characteristics, clinical signs and symptoms, comorbidities, blood tests results, chest computed tomography (CT) scan findings and outcomes including hospitalization, intensive care unit (ICU) admission and survival of the patients were recorded. Results: During the one week study period, we took 435 nasopharyngeal swabs from suspicious cases and found 22 patients (4 females, 18 males) whose COVID-19 infection was confirmed via RT-PCR. Their ages ranged from 18 to 86 years, with an average of 45.59±25.02. Ten (45%) of the cases were current smokers. The body temperature of the cases ranged from 36.1 to 38.4 oC, with an average of 36.78 ± 0.65. Four cases were asymptomatic and the most common complaint was cough (82%). Hypertension (23%) and chronic obstructive pulmonary disease (COPD) (23%) were the most common coexisting diseases. In chest CT scan, ground glass densities were detected in 7 (32%) patients and infiltration was observed in 8 (36.3%). The mortality rate of the cases was 9% (n=2). Conclusion: The most common complaint of patients was cough. Hypertension and COPD were the most prevalent comorbidities among patients.


Download data is not yet available.


1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.
2. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. COVID-19 in critically ill patients in the Seattle Region — Case Series. N Eng J Med. 2020. [In press].
3. Lescure FX, Bouadma L, Nguyen D, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet. 2020. [In press].
4. COVID-19 coronavirus pandemic: Reported Cases and Deaths by Country, Territory, or Conveyance. Avaiable at: https://www.worldometers.info/coronavirus/. [Accessed on April 14, 2020].
5. Arcavi L, Benowitz NL. Cigarette Smoking and Infection. Arch Intern Med. 2004;164(20):2206-16.
6. Feldman C, Anderson R. Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. J Infect. 2013;67(3):169-84.
7. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7:11.
8. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5.
9. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A Nationwide Analysis. Eur Respir J. 2020:2000547.
10. Cinkooglu A, Bayraktaroglu S, Savas R. Lung changes on chest CT during 2019 novel coronavirus (COVID-19) pneumonia. Eur J Breast Health. 2020;16(2):89-90.
11. He X, Zheng J, Ren JL, Zheng G, Liu L. Chest high-resolution computed tomography imaging findings of coronavirus disease 2019 (Covid-19) pneumonia. Int J Radiat Res. 2020;18(2):343-9.
How to Cite
Perincek G, Avci S. A Case Series of Patients with COVID-19 Infection Admitted to a Secondary Care Center in Turkey. Adv J Emerg Med. 4(2s):e49.
Original article